- $9.50bn
- $12.57bn
- $1.05bn
- 77
- 45
- 72
- 70
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 644 | 679 | 823 | 1,010 | 1,050 |
Cost of Revenue | |||||
Gross Profit | 434 | 456 | 591 | 739 | 780 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 412 | 440 | 566 | 669 | 548 |
Operating Profit | 232 | 240 | 257 | 341 | 502 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 171 | 168 | 231 | 292 | 412 |
Net Income After Taxes | 171 | 168 | 231 | 292 | 412 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 169 | 166 | 223 | 291 | 411 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 169 | 166 | 223 | 291 | 411 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.875 | 0.908 | 1.1 | 1.34 | 1.79 |
Dividends per Share |